Insulin Monocomponent -Lispra (rDNA) - Anti diabetic
Drug Name:
Insulin Monocomponent -Lispra (rDNA) - Anti diabetic
List Of Brands:
Indication Type Description:
Indication:
Anti-diabetic
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Insulin Monocomponent Anti-diabetic December 1997
Lispra (rDNA)
Dosages/ Overdosage Etc:
Anti-diabetic